Chevron’s Estimates Lowered Below Consensus and 4 Stock Analyses Making Headlines

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) price targethas been increased to $5 from $3 at Ladenburg.

Alcoa, Inc. (NYSE:AA) reported stronger  Q3 results than expected influencing Stifel Nicolaus to predict that general weakness will show a negative impact the company’s Q4 results. The firm believes that the weakness should be alleviated via increased aluminum prices. It keeps its Buy rating on the stock.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

FedEx Corporation (NYSE:FDX): According to JPMorgan, FedEx’s $1.7 billion target for operating income improvement in its cost plan is more than expected. The firm believes that there will be a positive response to shares, and it maintains its Overweight rating on the stock.

The McGraw-Hill Companies, Inc. (NYSE:MHP) price target was an increase to $64 from $54 at Jefferies.

Chevron Corp. (NYSE:CVX) Q3 estimates have been reduced by UBS to below consensus after its interim update because of the company’s production miss, FX impact, lower liquids realization, and increased corporate expenses. The firm keeps its Buy rating and $125 price target on the stock.

Don’t Miss: Chevron Loses Massive Appeal.


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business